Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (958) Arrow Down
Filter Results: (958) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (958)
    • People  (1)
    • News  (163)
    • Research  (530)
    • Multimedia  (6)
  • Faculty Publications  (269)

Show Results For

  • All HBS Web  (958)
    • People  (1)
    • News  (163)
    • Research  (530)
    • Multimedia  (6)
  • Faculty Publications  (269)
← Page 7 of 958 Results →
  • Article

One Obstacle to Curing Cancer: Patient Data Isn't Shared

By: Richard G. Hamermesh and Kathy Giusti
Precision Medicine requires large datasets to identify the mutations that lead to various cancers. Currently, genomic information is hoarded in fragmented silos within numerous academic medical centers, pharmaceutical companies, and some disease-based foundations. For... View Details
Keywords: Healthcare; Technological And Scientific Innovation; Cancer Care In The U.S.; Cancer Treatment; Precision Medicine; Personalized Medicine; Data Sharing; Technological Innovation; Analytics and Data Science; Health Disorders; Medical Specialties; Research and Development; Customization and Personalization; Health Industry; United States
Citation
Register to Read
Related
Hamermesh, Richard G., and Kathy Giusti. "One Obstacle to Curing Cancer: Patient Data Isn't Shared." Harvard Business Review (website) (November 28, 2016).
  • Web

Technology & Innovation - Faculty & Research

creation of disruptive innovations that displace earlier technologies; development of innovations in sectors; and the impact of innovation on... View Details
  • October 2022 (Revised September 2024)
  • Case

mPharma: Scaling Access to Affordable Primary Care in Africa

By: Regina E. Herzlinger and Ben Creo
mPharma hopes to scale up to create the largest pan-African healthcare company ever to provide much-needed primary care in retail pharmacies; a reliable, fairly priced supply of drugs; and micro-insurance for drugs. They must prioritize launching a telemedicine... View Details
Keywords: Africa; Pharmaceutical Companies; Pharmacy Benefit Manager; Health Care; Health Care And Treatment; Health Care Costs; Health Care Delivery; Health Care Entrepreneurship; Telehealth; Health Equity; Corporate Strategy; Social Entrepreneurship; Equity; Growth and Development Strategy; Expansion; Product Launch; Customer Value and Value Chain; Social Enterprise; Multinational Firms and Management; Pharmaceutical Industry; Health Industry; Africa
Citation
Educators
Purchase
Related
Herzlinger, Regina E., and Ben Creo. "mPharma: Scaling Access to Affordable Primary Care in Africa." Harvard Business School Case 323-033, October 2022. (Revised September 2024.)
  • 07 Jul 2008
  • Research & Ideas

Innovation Corrupted: How Managers Can Avoid Another Enron

"In the end, Enron was at the center of a truly delinquent society. Once Enron's ethical drift took hold, its collapse was only a matter of time," says HBS professor emeritus Malcolm S. Salter. As he explains in this Q&A and... View Details
Keywords: by Martha Lagace; Energy; Utilities
  • 01 Sep 2020
  • News

Turning Point: Change, Stat

The silver lining in all of this is that people have realized the emperor has no clothes. For decades, we’ve recognized that healthcare innovates dramatically slower than other... View Details
Keywords: COVID-19; healthcare; medicine; innovation; interpersonal communication; Ambulatory Health Care Services; Health, Social Assistance
  • 02 Apr 2015
  • Research & Ideas

Digital Initiative Summit: Freeing Patient Data to Enable Innovation

mending information gap in health care. Majmudar, whose own company is working at the intersection of health data and wearables, pushed future innovators to focus on ideas that will have measurable impacts... View Details
Keywords: Re: Karim R. Lakhani; Health
  • 01 Jun 2011
  • News

Student Teams Take on Real-World Innovation

second-year Managing Innovation course. He assigned all 105 students in his two sections to field projects with Ford, General Electric, NASA, and Nike. “Since the course is about innovation, the projects all... View Details
Keywords: Transportation Equipment Manufacturing; Manufacturing
  • February 2022 (Revised April 2022)
  • Case

CVS Health: Prescription for Transformation

By: Rosabeth Moss Kanter and Tuna Cem Hayirli
In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant. The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a... View Details
Keywords: COVID; Caregiving; Healthcare; Access; Change; Retail; Health; Health Care and Treatment; Organizational Change and Adaptation; Transformation; Health Industry; Retail Industry
Citation
Educators
Purchase
Related
Kanter, Rosabeth Moss, and Tuna Cem Hayirli. "CVS Health: Prescription for Transformation." Harvard Business School Case 322-091, February 2022. (Revised April 2022.)
  • September 2018
  • Article

Discretionary Task Ordering: Queue Management in Radiological Services

By: Maria Ibanez, Jonathan R. Clark, Robert S. Huckman and Bradley R. Staats
Work-scheduling research typically prescribes task sequences implemented by managers. Yet employees often have discretion to deviate from their prescribed sequence. Using data from 2.4 million radiological diagnoses, we find that doctors prioritize similar tasks... View Details
Keywords: Discretion; Scheduling; Queue; Healthcare; Learning; Experience; Decentralization; Operations; Service Operations; Service Delivery; Performance; Performance Effectiveness; Performance Efficiency; Performance Improvement; Performance Productivity; Decisions; Time Management; Cost vs Benefits; Health Industry
Citation
SSRN
Find at Harvard
Related
Ibanez, Maria, Jonathan R. Clark, Robert S. Huckman, and Bradley R. Staats. "Discretionary Task Ordering: Queue Management in Radiological Services." Management Science 64, no. 9 (September 2018): 4389–4407. (Working paper available here. Winner of the 2017 Best Paper Competition of the POMS College of Healthcare Operations Management. Featured in Forbes, Quartz, and Inc.)
  • 23 Nov 2009
  • Research & Ideas

Management’s Role in Reforming Health Care

Despite the urgency of debate on the U.S. national stage about health-care reform, an issue now before the U.S. Senate, one crucial element of change has been less visible: advances in the delivery of... View Details
Keywords: by Martha Lagace; Health
  • September 2016
  • Case

Health Leads: Reaching for Impact (A)

By: V. Kasturi Rangan and Sarah Appleby
Explores strategies to achieve system-level impact for a nonprofit focused on addressing patients' basic social needs through healthcare institutions. Founded in 1996 with a volunteer-staffed help desk at Boston Medical Center connecting low-income patients with basic... View Details
Keywords: Scaling Social Impact; Nonprofit; Healthcare; Health Care Outcomes; Health Care Reform; Health Care Delivery; Scaling Social Enterprise; Social Enterprise; Health; Nonprofit Organizations; Health Care and Treatment; Health Industry; United States
Citation
Educators
Purchase
Related
Rangan, V. Kasturi, and Sarah Appleby. "Health Leads: Reaching for Impact (A)." Harvard Business School Case 517-022, September 2016.
  • 26 Jan 2004
  • Research & Ideas

What Developing-World Companies Teach Us About Innovation

capitalists to fund big bets on technology, research universities that mint PhDs, and a clear legal framework that protects intellectual property. In stark contrast, companies in developing countries lack... View Details
Keywords: by Donald N. Sull, Alejandro Ruelas-Gossi & Martin Escobari
  • April 1993 (Revised October 1995)
  • Case

ALZA and Bio-Electro Systems (A): Technological and Financial Innovation

By: Josh Lerner and Peter Tufano
To develop the next generation of risky products, ALZA, a mature and profitable biotechnology firm specializing in drug delivery systems, must raise $40 million. Organizational constraints and competitive concerns demand that the work be done inside the firm. However,... View Details
Keywords: Risk and Uncertainty; Technological Innovation; Business Subsidiaries; Decision Choices and Conditions; Corporate Finance; Biotechnology Industry; Medical Devices and Supplies Industry
Citation
Educators
Purchase
Related
Lerner, Josh, and Peter Tufano. "ALZA and Bio-Electro Systems (A): Technological and Financial Innovation." Harvard Business School Case 293-124, April 1993. (Revised October 1995.)
  • 16 Nov 2021
  • News

Getting Back Together for Global Networking Night; Healthcare Conference Draws New Interest

lucky to have him!” Healthcare Alumni Hold Annual Conference On November 4 and 5, the HBS Healthcare Alumni Association (HBSHAA) held its 2021 Virtual Annual Conference, featuring View Details
Keywords: Margie Kelley
  • 10 AM – 11 AM EDT, 22 Oct 2015
  • Webinars: Trending@HBS

Collective Impact: An Innovative Approach to Improving Public Education

In this webinar, Professor Grossman will describe an innovative approach to improving public education Collective Impact and how you can get involved to help transform public education in the communities you care about. View Details
  • September 2017 (Revised February 2023)
  • Case

Intermountain Healthcare: Pursuing Precision Medicine

By: Richard G. Hamermesh, Kathy E. Giusti, Robert S. Huckman and Julia Kelley
Headquartered in Salt Lake City, Intermountain Healthcare operates 23 hospitals and hundreds of clinics in Utah and Idaho and provides insurance to approximately 850,000 patients through its insurance arm, SelectHealth. In 2013, Intermountain, known for its commitment... View Details
Keywords: Precision Medicine; Healthcare; Innovation; Cancer; Cancer Research; Health Care; Technology; Health Care and Treatment; Innovation Leadership; Disruptive Innovation; Entrepreneurship; Decision Choices and Conditions; Health Industry; Insurance Industry; Utah; United States; North America
Citation
Educators
Purchase
Related
Hamermesh, Richard G., Kathy E. Giusti, Robert S. Huckman, and Julia Kelley. "Intermountain Healthcare: Pursuing Precision Medicine." Harvard Business School Case 818-018, September 2017. (Revised February 2023.)
  • 06 Jul 2023
  • News

Lessons from Major League Baseball's Game-Changing Innovations

MLB, where he's worked since he graduated from HBS in 2008. And he's helped lead some of the transformational innovations the sport has undergone in the last decade, both on... View Details
  • 28 Nov 2016
  • Research & Ideas

Challenging the Belief that Liability Laws Kill Medical Device Innovation

incentivized to produce safer products to help them manage risk” “When physicians are under pressure from high liability, innovators are incentivized to produce safer products to help them manage risk,” says Hong Luo, an assistant... View Details
Keywords: by Michael Blanding; Medical Devices & Supplies
  • 15 Oct 2019
  • News

Innovative Thinking Fuels Nascent Startup Scene

Amira Rashad (MBA 1998) Amira Rashad (MBA 1998) When Amira Rashad (MBA 1998) cofounded the grocery delivery platform BulkWhiz in the United Arab Emirates (UAE) in spring 2017,... View Details
  • October 2014 (Revised April 2023)
  • Case

Gilead: Hepatitis C Access Strategy (A)

By: V. Kasturi Rangan, Vikram Rangan and David E. Bloom
Gilead had come up with an innovative drug for Hepatitis C, which affected 180 million people worldwide. The drug was priced at $1,000 a pill for the US market. Gilead had to decide how to price and market the pill in developing countries that bore the brunt of the... View Details
Keywords: Healthcare; Pharmaceuticals; Pricing; Access To Care; Emerging Markets; Health Care and Treatment; Price; Strategy; Ethics; Health Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Rangan, V. Kasturi, Vikram Rangan, and David E. Bloom. "Gilead: Hepatitis C Access Strategy (A)." Harvard Business School Case 515-025, October 2014. (Revised April 2023.)
  • ←
  • 7
  • 8
  • …
  • 47
  • 48
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.